Cargando…
Let-7 as biomarker, prognostic indicator, and therapy for precision medicine in cancer
Abnormal regulation and expression of microRNAs (miRNAs) has been documented in various diseases including cancer. The miRNA let-7 (MIRLET7) family controls developmental timing and differentiation. Let-7 loss contributes to carcinogenesis via an increase in its target oncogenes and stemness factors...
Autores principales: | Chirshev, Evgeny, Oberg, Kerby C., Ioffe, Yevgeniya J., Unternaehrer, Juli J. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer Berlin Heidelberg
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6715759/ https://www.ncbi.nlm.nih.gov/pubmed/31468250 http://dx.doi.org/10.1186/s40169-019-0240-y |
Ejemplares similares
-
Let-7i Reduces Aggressive Phenotype and Induces BRCAness in Ovarian Cancer Cells
por: Chirshev, Evgeny, et al.
Publicado: (2021) -
Epithelial/mesenchymal heterogeneity of high‐grade serous ovarian carcinoma samples correlates with miRNA let‐7 levels and predicts tumor growth and metastasis
por: Chirshev, Evgeny, et al.
Publicado: (2020) -
The Epithelial–Mesenchymal Transcription Factor SNAI1 Represses Transcription of the Tumor Suppressor miRNA let-7 in Cancer
por: Wang, Hanmin, et al.
Publicado: (2021) -
Role of epithelial-mesenchymal transition factor SNAI1 and its targets in ovarian cancer aggressiveness
por: Suzuki, Tise, et al.
Publicado: (2023) -
Racial and Ethnic Disparities in Gynecologic Carcinosarcoma: A Single-Institution Experience
por: Mercado, Kristina E., et al.
Publicado: (2023)